United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies from the United States as of Jul. 01, 2025

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
91 Celldex Therapeutics, Inc. $1.46 B United States US Healthcare US Biotechnology
92 Edgewise Therapeutics, Inc. $1.37 B United States US Healthcare US Biotechnology
93 Longboard Pharmaceuticals, Inc. $1.36 B

(July 1, 2024)

 United States US Healthcare US Biotechnology
94 Travere Therapeutics Inc. $1.33 B United States US Healthcare US Biotechnology
95 IMARA Inc. $1.32 B United States US Healthcare US Biotechnology
96 Viridian Therapeutics, Inc. $1.28 B United States US Healthcare US Biotechnology
97 Dyne Therapeutics, Inc. $1.24 B United States US Healthcare US Biotechnology
98 Dynavax Technologies Corporation $1.23 B United States US Healthcare US Biotechnology
99 Innoviva, Inc. $1.21 B United States US Healthcare US Biotechnology
100 Intellia Therapeutics, Inc. $1.11 B United States US Healthcare US Biotechnology
101 Novavax, Inc. $1.10 B United States US Healthcare US Biotechnology
102 MannKind Corporation $1.09 B United States US Healthcare US Biotechnology
103 Liquidia Corp $1.04 B United States US Healthcare US Biotechnology
104 Liquidia Corporation $1.04 B United States US Healthcare US Biotechnology
105 Alpine Immune Sciences, Inc. $1.03 B

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
106 Ardelyx, Inc. $1.02 B United States US Healthcare US Biotechnology
107 Cidara Therapeutics, Inc. $1.02 B United States US Healthcare US Biotechnology
108 Forma Therapeutics Holdings, Inc. $1.01 B

(Oct. 1, 2022)

 United States US Healthcare US Biotechnology
109 Verve Therapeutics, Inc. $1.01 B United States US Healthcare US Biotechnology
110 Maravai LifeSciences Holdings, Inc. $975.5 M United States US Healthcare US Biotechnology
111 Nurix Therapeutics, Inc. $970.5 M United States US Healthcare US Biotechnology
112 Praxis Precision Medicines, Inc. $962.6 M United States US Healthcare US Biotechnology
113 Akebia Therapeutics, Inc. $950.7 M United States US Healthcare US Biotechnology
114 Poseida Therapeutics, Inc. $925.9 M

(Jan. 1, 2025)

 United States US Healthcare US Biotechnology
115 Anavex Life Sciences Corp. $921.2 M United States US Healthcare US Biotechnology
116 ORIC Pharmaceuticals, Inc. $920.4 M United States US Healthcare US Biotechnology
117 Provention Bio, Inc. $912.0 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
118 Geron Corporation $910.8 M United States US Healthcare US Biotechnology
119 Albireo Pharma, Inc. $910.7 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
120 Arcus Biosciences, Inc. $896.8 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jul. 01, 2025

91. Celldex Therapeutics, Inc.

Company Profile: Celldex Therapeutics, Inc.
Market Cap (USD): $1.46 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

92. Edgewise Therapeutics, Inc.

Company Profile: Edgewise Therapeutics, Inc.
Market Cap (USD): $1.37 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

93. Longboard Pharmaceuticals, Inc.

Company Profile: Longboard Pharmaceuticals, Inc.
Market Cap (USD): $1.36 B (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

94. Travere Therapeutics Inc.

Company Profile: Travere Therapeutics Inc.
Market Cap (USD): $1.33 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

95. IMARA Inc.

Company Profile: IMARA Inc.
Market Cap (USD): $1.32 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

96. Viridian Therapeutics, Inc.

Company Profile: Viridian Therapeutics, Inc.
Market Cap (USD): $1.28 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

97. Dyne Therapeutics, Inc.

Company Profile: Dyne Therapeutics, Inc.
Market Cap (USD): $1.24 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

98. Dynavax Technologies Corporation

Company Profile: Dynavax Technologies Corporation
Market Cap (USD): $1.23 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

99. Innoviva, Inc.

Company Profile: Innoviva, Inc.
Market Cap (USD): $1.21 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

100. Intellia Therapeutics, Inc.

Company Profile: Intellia Therapeutics, Inc.
Market Cap (USD): $1.11 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

101. Novavax, Inc.

Company Profile: Novavax, Inc.
Market Cap (USD): $1.10 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

102. MannKind Corporation

Company Profile: MannKind Corporation
Market Cap (USD): $1.09 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

103. Liquidia Corp

Company Profile: Liquidia Corp
Market Cap (USD): $1.04 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

104. Liquidia Corporation

Company Profile: Liquidia Corporation
Market Cap (USD): $1.04 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

105. Alpine Immune Sciences, Inc.

Company Profile: Alpine Immune Sciences, Inc.
Market Cap (USD): $1.03 B (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

106. Ardelyx, Inc.

Company Profile: Ardelyx, Inc.
Market Cap (USD): $1.02 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

107. Cidara Therapeutics, Inc.

Company Profile: Cidara Therapeutics, Inc.
Market Cap (USD): $1.02 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

108. Forma Therapeutics Holdings, Inc.

Company Profile: Forma Therapeutics Holdings, Inc.
Market Cap (USD): $1.01 B (Oct. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

109. Verve Therapeutics, Inc.

Company Profile: Verve Therapeutics, Inc.
Market Cap (USD): $1.01 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

110. Maravai LifeSciences Holdings, Inc.

Company Profile: Maravai LifeSciences Holdings, Inc.
Market Cap (USD): $975.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

111. Nurix Therapeutics, Inc.

Company Profile: Nurix Therapeutics, Inc.
Market Cap (USD): $970.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

112. Praxis Precision Medicines, Inc.

Company Profile: Praxis Precision Medicines, Inc.
Market Cap (USD): $962.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

113. Akebia Therapeutics, Inc.

Company Profile: Akebia Therapeutics, Inc.
Market Cap (USD): $950.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

114. Poseida Therapeutics, Inc.

Company Profile: Poseida Therapeutics, Inc.
Market Cap (USD): $925.9 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

115. Anavex Life Sciences Corp.

Company Profile: Anavex Life Sciences Corp.
Market Cap (USD): $921.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

116. ORIC Pharmaceuticals, Inc.

Company Profile: ORIC Pharmaceuticals, Inc.
Market Cap (USD): $920.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

117. Provention Bio, Inc.

Company Profile: Provention Bio, Inc.
Market Cap (USD): $912.0 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

118. Geron Corporation

Company Profile: Geron Corporation
Market Cap (USD): $910.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

119. Albireo Pharma, Inc.

Company Profile: Albireo Pharma, Inc.
Market Cap (USD): $910.7 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

120. Arcus Biosciences, Inc.

Company Profile: Arcus Biosciences, Inc.
Market Cap (USD): $896.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch